Novo Integrated Sciences Current Ratio 2012-2024 | NVOS
Novo Integrated Sciences current ratio from 2012 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Novo Integrated Sciences Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-08-31 | $0.01B | $0.02B | 0.37 |
| 2024-05-31 | $0.01B | $0.02B | 0.27 |
| 2024-02-29 | $0.01B | $0.01B | 0.50 |
| 2023-11-30 | $0.01B | $0.01B | 0.62 |
| 2023-08-31 | $0.00B | $0.01B | 0.56 |
| 2023-05-31 | $0.00B | $0.01B | 0.64 |
| 2023-02-28 | $0.00B | $0.01B | 0.66 |
| 2022-11-30 | $0.00B | $0.01B | 0.36 |
| 2022-08-31 | $0.01B | $0.01B | 0.41 |
| 2022-05-31 | $0.02B | $0.01B | 1.58 |
| 2022-02-28 | $0.02B | $0.01B | 1.65 |
| 2021-11-30 | $0.01B | $0.02B | 0.78 |
| 2021-08-31 | $0.01B | $0.01B | 1.32 |
| 2021-05-31 | $0.01B | $0.00B | 3.07 |
| 2021-02-28 | $0.00B | $0.00B | 0.99 |
| 2020-11-30 | $0.00B | $0.00B | 1.60 |
| 2020-08-31 | $0.00B | $0.00B | 1.65 |
| 2020-05-31 | $0.00B | $0.00B | 1.55 |
| 2020-02-29 | $0.00B | $0.00B | 1.55 |
| 2019-11-30 | $0.00B | $0.00B | 1.41 |
| 2019-08-31 | $0.00B | $0.00B | 1.35 |
| 2019-05-31 | $0.01B | $0.01B | 1.00 |
| 2019-02-28 | $0.01B | $0.00B | 1.48 |
| 2018-11-30 | $0.00B | $0.00B | 0.85 |
| 2018-08-31 | $0.00B | $0.00B | 0.77 |
| 2018-05-31 | $0.00B | $0.00B | 0.95 |
| 2018-02-28 | $0.00B | $0.00B | 0.98 |
| 2017-11-30 | $0.00B | $0.00B | 0.80 |
| 2017-08-31 | $0.00B | $0.00B | 0.85 |
| 2017-05-31 | $0.01B | $0.01B | 0.49 |
| 2017-03-31 | $0.00B | $0.00B | 4.47 |
| 2017-02-28 | $0.00B | 0.00 | |
| 2016-12-31 | $0.00B | 0.00 | |
| 2016-11-30 | $0.00B | 0.00 | |
| 2016-09-30 | $0.00B | $0.00B | 4.27 |
| 2016-06-30 | $0.00B | $0.00B | 1.86 |
| 2016-05-31 | $0.00B | 0.00 | |
| 2016-03-31 | $0.00B | $0.00B | 1.25 |
| 2015-12-31 | $0.00B | 0.00 | |
| 2015-09-30 | $0.00B | $0.00B | 0.73 |
| 2015-06-30 | $0.00B | $0.00B | 0.15 |
| 2015-03-31 | $0.00B | $0.00B | 0.09 |
| 2014-12-31 | $0.00B | 0.00 | |
| 2014-09-30 | $0.00B | $0.00B | 0.33 |
| 2014-06-30 | $0.00B | $0.00B | 0.43 |
| 2014-03-31 | $0.00B | $0.00B | 0.72 |
| 2013-12-31 | $0.00B | 0.00 | |
| 2013-09-30 | $0.00B | $0.00B | 0.38 |
| 2013-06-30 | $0.00B | $0.00B | 0.03 |
| 2013-03-31 | $0.00B | $0.00B | 0.16 |
| 2012-12-31 | $0.00B | $0.00B | 0.07 |
| 2012-09-30 | $0.00B | $0.00B | 0.27 |
| 2012-08-31 | $0.00B | 0.00 | |
| 2012-06-30 | $0.00B | $0.00B | 0.32 |
| 2012-03-31 | $0.00B | $0.00B | 0.20 |
| 2012-02-29 | $0.00B | 0.00 | |
| 2011-12-31 | $0.00B | $0.00B | 0.13 |
| 2011-11-30 | $0.00B | 0.00 | |
| 2011-09-30 | $0.00B | 0.00 | |
| 2011-08-31 | $0.00B | 0.00 | |
| 2011-06-30 | $0.00B | 0.00 | |
| 2011-05-31 | $0.00B | 0.00 | |
| 2011-03-31 | $0.00B | 0.00 | |
| 2011-02-28 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.000B | $0.013B |
| Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |